Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) have been given an average rating of "Moderate Buy" by the thirteen research firms that are covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $63.42.

Several equities analysts have recently issued reports on the company. Piper Sandler upped their price target on Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a research note on Thursday, May 15th. Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Needham & Company LLC restated a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a report on Wednesday, May 7th. Bank of America lifted their target price on shares of Tempus AI from $48.00 to $68.00 and gave the stock a "neutral" rating in a report on Tuesday, May 20th. Finally, BTIG Research started coverage on Tempus AI in a research note on Monday, April 21st. They issued a "buy" rating and a $60.00 price target on the stock.

Insider Transactions at Tempus AI

In related news, Director Wayne A.I. Frederick sold 3,000 shares of the firm's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the transaction, the director now directly owns 26,514 shares of the company's stock, valued at approximately $1,207,447.56. This trade represents a 10.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nadja West sold 809 shares of the stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $51.11, for a total transaction of $41,347.99. Following the transaction, the director now owns 37,705 shares in the company, valued at approximately $1,927,102.55. The trade was a 2.10% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 723,042 shares of company stock worth $37,642,690 over the last quarter. Company insiders own 27.60% of the company's stock.

Institutional Investors Weigh In On Tempus AI

Large investors have recently added to or reduced their stakes in the stock. SG Americas Securities LLC acquired a new stake in Tempus AI during the fourth quarter worth about $372,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Tempus AI during the 4th quarter worth $1,091,000. Renaissance Capital LLC grew its position in Tempus AI by 121.3% in the fourth quarter. Renaissance Capital LLC now owns 24,757 shares of the company's stock valued at $836,000 after acquiring an additional 13,569 shares during the last quarter. abrdn plc bought a new position in shares of Tempus AI in the fourth quarter worth about $2,784,000. Finally, James J. Burns & Company LLC bought a new position in shares of Tempus AI in the fourth quarter worth about $236,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Price Performance

Shares of Tempus AI stock traded up $0.15 during trading on Friday, reaching $54.58. The company's stock had a trading volume of 14,044,467 shares, compared to its average volume of 6,679,517. Tempus AI has a one year low of $22.89 and a one year high of $91.45. The stock has a 50-day moving average price of $52.07 and a two-hundred day moving average price of $51.90. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The stock has a market capitalization of $9.40 billion and a P/E ratio of -7.00.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. The company had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI's quarterly revenue was up 75.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that Tempus AI will post -6.15 EPS for the current fiscal year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.